Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jupiter Endovascular

Explore full profile

Innovative endovascular devices enhancing cardiovascular health with cutting-edge technology

Menlo Park, United StatesFounded 2024Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Jupiter Endovascular and the history behind them.

About Jupiter Endovascular

Jupiter Endo is a medical technology company specializing in the development and commercialization of advanced endovascular devices aimed at improving cardiovascular health. The company serves healthcare providers, including hospitals and specialized cardiovascular clinics, operating in the global cardiovascular medical device market. Jupiter Endo's business model focuses on the research, development, and sale of innovative medical devices designed to treat various cardiovascular conditions. Revenue is generated through the direct sale of these devices to healthcare institutions and through strategic partnerships with other medical technology firms. The company leverages its extensive expertise in clinical affairs and product management to bring cutting-edge solutions to market, ensuring high standards of safety and efficacy.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2024
Headquarters
Menlo Park, United States
Employees
57
Open positions
11
Dealroom signal
0.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Oct 2025 $40M $160M Senvest Capital · Sonder Capital · LB Investment ↗
CORPORATE SPINOUT✓Other financing Aug 2024 $0 — Neptune Medical ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Jupiter Endovascular website traffic

Latest recorded traffic for Jupiter Endovascular is 2.1K monthly website visits, up 90.9% over the last three months. Jupiter Endovascular's team grew 200% over the past year.

Latest monthly visits2.1K 3-month web change+90.9% 1-year team growth+200%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Sonder Capital
  • Senvest Capital
  • LB Investment

Series B and later1 investor entered at this stage

  • Neptune Medical
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jupiter Endovascular on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jupiter Endovascular’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.